Insider · CIK 0002007659
Mark C. Schiller
Files at KZR (Kezar Life Sciences, Inc.). First filing Jul 3, 2025, latest Jul 3, 2025.
Mark C. Schiller files SEC Form 4 as COO at KZR (Kezar Life Sciences, Inc.). Since Jul 3, 2025, Mark C. Schiller has reported 0 open-market buys worth $0 and 1 open-market sell worth $2,401, the latest filed on Jul 3, 2025.
A track record needs three past buys with six months of prices behind them; Mark C. Schiller has 0, so none is measured yet.
The newest scored trade: sold $2,401 of KZR on Jul 2, 2025, filed Jul 3, 2025, scored 33 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Kezar Life Sciences, Inc. | $2,401 561 shares | -17% | - |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | UTender of shares Common Stock | -2,739 | - | - | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -24,500 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -12,000 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -4,999 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -2,499 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -5,249 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -11,000 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -12,999 | $0.00 | $0 | 0 | May 11, 2026 |
| May 11, 2026 | KZR Kezar Life Sciences, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -16,499 | $0.00 | $0 | 0 | May 11, 2026 |
| Jul 2, 2025 | KZR Kezar Life Sciences, Inc. | SOpen-market sale Common Stock | -561 | $4.28 | $2,401 | 2,739 | Jul 3, 2025 |
| Mar 27, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +4,800 | $0.00 | $0 | 12,000 | Apr 1, 2025 |
| Mar 4, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +7,200 | $0.00 | $0 | 7,200 | Mar 5, 2025 |
| Jan 9, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +24,500 | $0.00 | $0 | 24,500 | Jan 13, 2025 |
Questions about Mark C. Schiller
Answered from the filings on this page, as of the latest one.
Is Mark C. Schiller buying or selling?
Not in the last 12 months. Mark C. Schiller's latest open-market trade on SEC Form 4 was sold $2,401 of KZR on Jul 2, 2025.
How did Mark C. Schiller's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark C. Schiller has 0.
Where does Mark C. Schiller file Form 4?
Mark C. Schiller has filed Form 4 at KZR (Kezar Life Sciences, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.